1. Home
  2. OTH vs ADVM Comparison

OTH vs ADVM Comparison

Compare OTH & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OTH

Off The Hook YS Inc. Common Stock

N/A

Current Price

$3.20

Market Cap

82.7M

Sector

Industrials

ML Signal

N/A

Logo Adverum Biotechnologies Inc.

ADVM

Adverum Biotechnologies Inc.

HOLD

Current Price

$4.31

Market Cap

94.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTH
ADVM
Founded
2012
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.7M
94.6M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
OTH
ADVM
Price
$3.20
$4.31
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.60
AVG Volume (30 Days)
154.8K
495.1K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$105,737,814.00
N/A
Revenue This Year
N/A
$1,192.00
Revenue Next Year
N/A
N/A
P/E Ratio
$58.58
N/A
Revenue Growth
7.79
N/A
52 Week Low
$3.01
$1.78
52 Week High
$3.90
$6.12

Technical Indicators

Market Signals
Indicator
OTH
ADVM
Relative Strength Index (RSI) N/A 55.88
Support Level N/A $4.15
Resistance Level N/A $4.23
Average True Range (ATR) 0.00 0.09
MACD 0.00 0.01
Stochastic Oscillator 0.00 96.02

Price Performance

Historical Comparison
OTH
ADVM

About OTH Off The Hook YS Inc. Common Stock

Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Boat Sales and Azure Funding. Boat Sales includes Specializing in the buying, selling, and wholesaling of yachts and boats, having a boat dealership created to run Yellow Fin sales in Miami; and Azure Funding includes a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: